Switch to:
More From Other Websites
Alnylam Reports Positive Data on Fitusiran, Givosiran Dec 05 2016
Pfizer (PFE) Presents Favorable Data on Leukemia Candidate Dec 05 2016
Incyte Jakafi Positive in Pooled Analysis of Five-Year Data Dec 05 2016
Merck KGaA (MKGAF) Expands Distribution Deal with Roche Dec 02 2016
AbbVie Crohn's Disease Drug Gets Orphan Drug Status in U.S. Dec 01 2016
Agenus' INCAGN1876 in Phase I/II Study for Solid Tumors Dec 01 2016
CAMBREX CORP Financials Nov 30 2016
Novo Nordisk's Tresiba Shows Safe Cardiovascular Profile Nov 30 2016
Zacks.com featured highlights: Forestar Real Estate Group, McDermott International, Coherent,... Nov 30 2016
Zacks.com featured highlights: Alliance Resource Partners, EnerSys, Cambrex and Children's Place Nov 29 2016
Zacks.com featured highlights: Edgewell Personal Care, Cambrex, Humana, Research Frontiers and... Nov 29 2016
Hedge Funds Are Buying Cambrex Corporation (CBM) Nov 28 2016
Bet on These 4 Top Stocks with Upgraded Broker Ratings Nov 28 2016
Glaxo (GSK) Files Regulatory Application for Shingrix in EU Nov 28 2016
Bet on Stocks with Rising P/E to Enjoy Growing Gains Nov 28 2016
Why You Shouldn't Bet Against Cambrex (CBM) Stock Nov 22 2016
Acorda Stops Post-Stroke Development Program on Ampyra Nov 22 2016
Zacks.com featured highlights: Stamps.com, Cambrex, Gibraltar Industries and FutureFuel Nov 21 2016
Spectrum (SPPI) Gets CRL for Bladder Cancer Drug in U.S. Nov 21 2016
J&J (JNJ) Files for Psoriasis Candidate Guselkumab in U.S. Nov 18 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK